Literature DB >> 21953748

Cardiogenic shock complicating acute myocardial infarction in the elderly: predictors of long-term survival.

Francesco Tomassini1, Andrea Gagnor, Alessandro Migliardi, Emanuele Tizzani, Vincenzo Infantino, Sara Giolitto, Maria Rosa Conte, Gaetano Antonio Lanza, Roberto Gnavi, Ferdinando Varbella.   

Abstract

BACKGROUND: Cardiogenic shock (CS) is a severe complication of acute myocardial infarction (AMI), associated with a high mortality. A significant improvement in survival has been reported with immediate coronary revascularization. However, there is no clear evidence of such an improvement amongst older patients. The aim of our work was to evaluate in-hospital and long-term outcomes in the group of elderly AMI patients with CS (≥75 years old).
METHODS: We collected data of 157 consecutive AMI patients with CS who underwent percutaneous coronary intervention (PCI) and compared clinical and procedural characteristics and in-hospital and long-term outcomes between patients <75 years and patients ≥75 years old.
RESULTS: There were 58 patients (36.9%) with age ≥75 years and 99 patients (63.1%) with age <75 years. Patients were followed up for an average period of 34 months (range 5-69). In-hospital and long-term mortality was significantly higher in the older group (55 vs. 25%, P < 0.0001; and 62.1 vs. 37.3%, P = 0.005, respectively). Multivariate predictors of in-hospital mortality were age ≥75 years (hazard ratio 1.81, 95% CI 1.006-3.27, P = 0.04) and PCI failure (hazard ratio 2.67, 95% CI 1.34-5.307, P = 0.005), whereas, the only multivariate predictor of long-term mortality was PCI failure (hazard ratio 2.88, 95% CI 1.52-5.46, P = 0.001). Age ≥75 years showed only a trend toward statistical significance (hazard ratio 1.62, 95% CI 0.96-2.76, P = 0.07).
CONCLUSIONS: In elderly AMI patients with CS, PCI can be performed with an acceptable risk that seems lower than that reported in most previous studies.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21953748     DOI: 10.1002/ccd.22911

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

1.  Outcome of elderly patients with circulatory failure.

Authors:  Patrick Biston; Cesar Aldecoa; Jacques Devriendt; Christian Madl; Didier Chochrad; Jean-Louis Vincent; Daniel De Backer
Journal:  Intensive Care Med       Date:  2013-10-17       Impact factor: 17.440

2.  Percutaneous coronary intervention for acute myocardial infarction in elderly patients with renal dysfunction: results from the Korea Acute Myocardial Infarction Registry.

Authors:  Sang Yup Lim; Eun Hui Bae; Joon Seok Choi; Chang Seong Kim; Seong Kwon Ma; Youngkeun Ahn; Myung Ho Jeong; Weon Kim; Jong Shin Woo; Young Jo Kim; Myeong Chan Cho; Chong Jin Kim; Soo Wan Kim
Journal:  J Korean Med Sci       Date:  2013-07-03       Impact factor: 2.153

Review 3.  Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock.

Authors:  Deepak Acharya
Journal:  Cardiol Rev       Date:  2018 Sep/Oct       Impact factor: 2.644

4.  Nomogram for Predicting In-Hospital Mortality in Patients with Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock after Primary Percutaneous Coronary Intervention.

Authors:  Yudan Wang; Litian Liu; Xinning Li; Yi Dang; Yingxiao Li; Jiaqi Wang; Xiaoyong Qi
Journal:  J Interv Cardiol       Date:  2022-03-12       Impact factor: 2.279

5.  Cardiogenic Shock Does Not Portend Poor Long-Term Survival in Patients Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Eva Steinacher; Felix Hofer; Niema Kazem; Andreas Hammer; Lorenz Koller; Irene Lang; Christian Hengstenberg; Alexander Niessner; Patrick Sulzgruber
Journal:  J Pers Med       Date:  2022-07-22

6.  One-year clinical outcomes in invasive treatment strategies for acute ST-elevation myocardial infarction complicated by cardiogenic shock in elderly patients.

Authors:  Yeon Pyo Yoo; Ki-Woon Kang; Hyeon Soo Yoon; Jin Cheol Myung; Yu Jeong Choi; Won Ho Kim; Sang Hyun Park; Kyung Tae Jung; Myung Ho Jeong
Journal:  J Geriatr Cardiol       Date:  2013-09       Impact factor: 3.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.